231 related articles for article (PubMed ID: 25416319)
1. The economic impact of chronic pain: a nationwide population-based cost-of-illness study in Portugal.
Azevedo LF; Costa-Pereira A; Mendonça L; Dias CC; Castro-Lopes JM
Eur J Health Econ; 2016 Jan; 17(1):87-98. PubMed ID: 25416319
[TBL] [Abstract][Full Text] [Related]
2. Chronic pain and health services utilization: is there overuse of diagnostic tests and inequalities in nonpharmacologic treatment methods utilization?
Azevedo LF; Costa-Pereira A; Mendonça L; Dias CC; Castro-Lopes JM
Med Care; 2013 Oct; 51(10):859-69. PubMed ID: 23969588
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of chronic pain: a population-based nationwide study on its prevalence, characteristics and associated disability in Portugal.
Azevedo LF; Costa-Pereira A; Mendonça L; Dias CC; Castro-Lopes JM
J Pain; 2012 Aug; 13(8):773-83. PubMed ID: 22858343
[TBL] [Abstract][Full Text] [Related]
4. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
5. The impact of osteoarthritis on early exit from work: results from a population-based study.
Laires PA; Canhão H; Rodrigues AM; Eusébio M; Gouveia M; Branco JC
BMC Public Health; 2018 Apr; 18(1):472. PubMed ID: 29642918
[TBL] [Abstract][Full Text] [Related]
6. The economic impact of early retirement attributed to rheumatic diseases: results from a nationwide population-based epidemiologic study.
Laires PA; Gouveia M; Canhão H; Branco JC
Public Health; 2016 Nov; 140():151-162. PubMed ID: 27527846
[TBL] [Abstract][Full Text] [Related]
7. Societal costs of multiple sclerosis in Ireland.
Carney P; O'Boyle D; Larkin A; McGuigan C; O'Rourke K
J Med Econ; 2018 May; 21(5):425-437. PubMed ID: 29320900
[TBL] [Abstract][Full Text] [Related]
8. Costs and quality of life of multiple sclerosis in Switzerland.
Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
[TBL] [Abstract][Full Text] [Related]
9. Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
Ruutiainen J; Viita AM; Hahl J; Sundell J; Nissinen H
J Med Econ; 2016; 19(1):21-33. PubMed ID: 26360615
[TBL] [Abstract][Full Text] [Related]
10. Burden of illness: direct and indirect costs among persons with hemophilia A in the United States.
Zhou ZY; Koerper MA; Johnson KA; Riske B; Baker JR; Ullman M; Curtis RG; Poon JL; Lou M; Nichol MB
J Med Econ; 2015 Jun; 18(6):457-65. PubMed ID: 25660324
[TBL] [Abstract][Full Text] [Related]
11. The burden associated with neuropathic pain in Western Europe.
Langley PC; Van Litsenburg C; Cappelleri JC; Carroll D
J Med Econ; 2013; 16(1):85-95. PubMed ID: 22970839
[TBL] [Abstract][Full Text] [Related]
12. Costs and quality of life of multiple sclerosis in Italy.
Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and social burden of active chronic low back pain in the adult Portuguese population: results from a national survey.
Gouveia N; Rodrigues A; Eusébio M; Ramiro S; Machado P; Canhão H; Branco JC
Rheumatol Int; 2016 Feb; 36(2):183-97. PubMed ID: 26661091
[TBL] [Abstract][Full Text] [Related]
14. Costs and quality of life of multiple sclerosis in Sweden.
Berg J; Lindgren P; Fredrikson S; Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
16. Costs and quality of life in multiple sclerosis in The Netherlands.
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
[TBL] [Abstract][Full Text] [Related]
17. Costs and quality of life for patients with multiple sclerosis in Belgium.
Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
[TBL] [Abstract][Full Text] [Related]
18. Costs and quality of life of multiple sclerosis in the United Kingdom.
Kobelt G; Berg J; Lindgren P; Kerrigan J; Russell N; Nixon R
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S96-104. PubMed ID: 17310341
[TBL] [Abstract][Full Text] [Related]
19. Costs and quality of life of multiple sclerosis in Spain.
Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
[TBL] [Abstract][Full Text] [Related]
20. Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study.
Chuvarayan Y; Finger RP; Köberlein-Neu J
Eur J Health Econ; 2020 Feb; 21(1):115-127. PubMed ID: 31493181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
